(*) EU Approval Date: 2013. 05.24.
(*) USA Approval Date: 2012. 11.02.
Company Intl. (Ex. USA)
Company USA
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 13
Patent>UpDate: 2018. 01.30.
Rivaroxaban Tablets
TradeMark
TradeMark Web-Site USA